RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
RxSight, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$4.69+0.18 (+3.99%)
Close on Oct 19, 2026
- Market cap
- $194.59M
- P/E (TTM)
- –
- Dividend yield
- –
RxSight, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| LAL | $108.06M | $96.50M | $54.09M | $24.97M | – | $4.26M | 80.4% | +12.0% |
| L D D | $20.67M | $39.70M | $32.09M | $22.52M | $13.77M | $10.16M | 15.4% | -47.9% |
| Service Warranty Service Contracts And Accessories | $5.75M | $3.73M | $2.89M | $1.53M | $656.00K | $263.00K | 4.3% | +54.3% |
| Balance at beginning of period | – | – | – | – | $540.00K | $345.00K | – | – |
| L A L | – | – | – | – | $8.16M | – | – | – |
| Additions during the period | – | – | – | $2.05M | $793.00K | – | – | – |
| Revenue recognized during the period | – | – | – | -$1.41M | -$598.00K | – | – | – |
| Balance at end of period | – | – | – | $1.19M | $540.00K | – | – | – |
By region
From the segment and revenue-disaggregation notes of RxSight's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.